UBS AM
KBIO

UBS AM’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

UBS AM’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-201,900
Closed -$2.79M – 2695
2014
Q4 		$2.79M Buy
201,900
+10,090
+5% +$144K ﹤0.01% 1205
2014
Q3 		$2.38M Buy
191,810
+56,248
+41% +$776K ﹤0.01% 1248
2014
Q2 		$2.47M Sell
135,562
-2,711
-2% -$46.4K ﹤0.01% 1251
2014
Q1 		$3M Buy
138,273
+25,516
+23% +$739K ﹤0.01% 1179
2013
Q4 		$3.99M Buy
112,757
+91,219
+424% +$3.06M ﹤0.01% 1060
2013
Q3 		$779K Buy
21,538
+9,425
+78% +$429K ﹤0.01% 1597
2013
Q2 		$548K Buy
+12,113
New +$549K ﹤0.01% 1669

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $46.9M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return